Suchergebnisse - "Bonanni, Laura"

PubPharm (67)

61

Botulinum toxin treatment of lateral axial dystonia in parkinsonism

enthalten in: Movement disorders | 2007

von Bonanni, L. | Thomas, A. | Varanese, S. | +2

62

New approaches to understanding hallucinations in Parkinson's disease: phenomenology and possible origins

enthalten in: Expert review of neurotherapeutics | 2007

von Onofrj, M. | Thomas, A. | Bonanni, L.

63

End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease

enthalten in: Journal of neurology | 2006

von Thomas, A. | Bonanni, L. | Di Iorio, A. | +5

64

End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson’s disease

enthalten in: Journal of neurology | 2006

von Thomas, A. | Bonanni, L. | Iorio, A. | +5

65

Zinc-Dependent Multi-Conductance Channel Activity in Mitochondria Isolated from Ischemic Brain

enthalten in: The journal of neuroscience | 2006

von Bonanni, L. | Chachar, M. | Jover-Mengual, T. | +6

66

ORIGINAL ARTICLES - Donepezil, Rivastigmine, and Vitamin E in Alzheimer Disease: A Combined P300 Event-related Potentials-Neuropsychologic Evaluation over 6 Months

enthalten in: Clinical neuropharmacology | 2001

von Thomas, A. | Iacono, D. | Bonanni, L. | +2

67

RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-b-1b

enthalten in: Journal of neuroimmunology | 2000

von Iarlori, C. | Reale, M. | Lugaresi, A. | +6

[1]
« Vorheriger
1
2
3
4
5
6
7